Andrew Hamer

Andrew Hamer

Company: Cardiol Therapeutics

Job title: Chief Medical Officer


Moving Beyond Symptom Suppression: Targeting NLRP3 Inflammasome for Disease Modification in Cardiac Conditions 3:00 pm

Targeting the NLRP3 Inflammasome shifting towards addressing the root causes of cardiac conditions, moving beyond traditional symptom management approaches Examining the complex interplay between inflammation, fibrosis, and disease progression Exploring the promise in delaying disease recurrences and modifying the underlying pathophysiology of cardiac conditionsRead more

day: Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.